Tetrandrine ameliorated reperfusion injury of small bowel transplantation

Journal of Pediatric Surgery

Volumn 44, Issue 11, 2009, Pages 2145-2152

  Chen, Yun ^a,b   Wu, Jiann Ming ^a   Lin, Tzu Yu ^a,b   Wu, Chia Chan ^a   Chiu, Kuan Ming ^a   Chang, Bee Feng ^a   Tseng, Sheng Hong ^b,c   Chu, Shu Hsun ^a  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b YUAN ZE UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Reperfusion injury; Small bowel transplantation; Tetrandrine

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELOPEROXIDASE; TETRANDRINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTESTINE TRANSPLANTATION; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMALL INTESTINE; STAINING; SWINE; TISSUE LEVEL;

ANIMALS; BENZYLISOQUINOLINES; CYTOKINES; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTESTINE, SMALL; MALE; NEUTROPHIL INFILTRATION; REPERFUSION INJURY; SWINE;

EID: 70449921677     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2009.06.002     Document Type: Article

References (33)

1. Chan K.L., Chan C.W., and Tam P.K.H. Segmental small bowel allograft-ischemic injury and regeneration. J Pediatr Surg 33 (1998) 1703-1706
2. Ho L.J., Chang D.M., Chang M.L., et al. Mechanism of immunosuppression of the antirheumatic herb TWHf in human T cells. J Rheumatol 26 (1999) 14-22
3. Kondo Y., Takano F., and Hojo H. Suppression of lipopolysaccharide-induced fulminant hepatitis and tumor necrosis factor production by bis-benzylisoquinoline alkaloids in bacillus Calmette-Guerin-treated mice. Biochem Pharmacol 46 (1993) 1861-1863
4. Lee S.H., Nan J.X., and Sohn D.H. Tetrandrine prevents tissue inhibitor of metalloproteinase-1 messenger RNA expression in rat liver fibrosis. Pharmacol Toxicol 89 (2001) 214-216
5. Lin T.Y., Tseng S.H., Lin S.J., et al. Tetrandrine increased the survival rate of mice with lipopolysaccharide-induced endotoxemia. J Trauma 66 (2009) 411-417
6. Liu B.C., He Y.X., Miao Q., et al. The effect of tetrandrine and polyvinylpyridine-N-oxide (PVNO) on gene expression of type I and III collagens during experimental silicosis. Biomed Environ Sci 7 (1994) 199-204
7. Xiao J., Wu S., Wang Y., et al. Inhibitory effects of tetrandrine on bovine serum albumin-induced uveitis in rabbits. J Ocular Pharmacol 9 (1993) 151-156
8. Wang G., Lemos J.R., and Iadecola C. Herbal alkaloid tetrandrine: from an ion channel blocker to inhibitor of tumor proliferation. Trends Pharmacol Sci 25 (2004) 120-123
9. Huang Y.T., Cheng Y.R., Lin H.C., et al. Haemodynamic effects of chronic tetrandrine treatment in portal hypertensive rats. J Gastroenterol Hepatol 12 (1997) 585-589
10. Lieberman I., Lentz D.P., Trucco G.A., et al. Prevention by tetrandrine of spontaneous development of diabetes mellitus in BB rats. Diabetes 41 (1992) 616-619
11. Shen Y.C., Chen C.F., and Sung Y.J. Tetrandrine ameliorates ischaemia-reperfusion injury of rat myocardium through inhibition of neutrophil priming and activation. Br J Pharmacol 128 (1999) 1593-1601
12. Wang H.L., Kilfeather S.A., Martin G.R., et al. Effects of tetrandrine on growth factor-induced DNA synthesis and proliferative response of rat pulmonary artery smooth muscle cells. Pulm Pharmacol Ther 13 (2000) 53-60
13. Chen Y., Chen J.C., and Tseng S.H. Tetrandrine suppresses tumor growth and angiogenesis of gliomas in rats. Int J Cancer 124 (2009) 2260-2269
14. Jang B.C., Lim K.J., Paik J.H., et al. Tetrandrine-induced apoptosis is mediated by activation of caspases and PKC-δ in U937 cells. Biochem Pharmacol 67 (2004) 1819-1829
15. Ng L.T. Antiproliferative and apoptotic effects of tetrandrine on different human hepatoma cell lines. Am J Chin Med 34 (2006) 125-135
16. Hui S.C.G., Chan T.Y., and Chen Y.Y. Tetrandrine inhibits lipid peroxidation but lacks reactivity towards superoxide anion and hydrogen peroxide. Pharmacol Toxicol 78 (1996) 200-201
17. Koh S.B., Ban J.Y., Lee B.Y., et al. Protective effects of fangchinoline and tetrandrine on hydrogen peroxide-induced oxidative neuronal cell damage in cultured rat cerebellar granule cells. Planta Med 69 (2003) 506-512
18. Liu S.J., Zhou S.W., and Xue C.S. Effect of tetrandrine on neutrophilic recruitment response to brain ischemia/reperfusion. Acta Pharmacol Sin 22 (2001) 971-975
19. Liu Z., Xu Z., Shen W., et al. Effect of pharmacologic preconditioning with tetrandrine on subsequent ischemia/reperfusion injury in rat liver. World J Surg 28 (2004) 620-624
20. Nadalin S., Biglania A.R., Testa G., et al. Role and significance of plasma citrulline in the early phase after small bowel transplantation in pigs. Transplant Int 20 (2007) 425-431
21. Herman E.H., and Chadwick D.P. Cardiovascular effects of d-Tetrandrine. Pharmacology 12 (1974) 97-109
22. Zeng F.D., Shaw Jr. D.H., and Ogilvie R.I. Kinetic disposition and hemodynamic effects of tetrandrine in anesthesized dogs. J Cardiovasc Pharmacol 7 (1985) 1034-1039
23. Chiu C.J., McArdle A.H., Brown R., et al. Intestinal mucosal lesion in low-flow states. I. A morphological hemodynamic, and metabolic reappraisal. Arch Surg 101 (1970) 478-483
24. Pascher A., and Klupp J. Biologics in the treatment of transplant rejection and ischemia/reperfusion injury. Biodrugs 19 (2005) 211-231
25. Laskowski I., Pratschke J., Wilhelm M.J., et al. Molecular and cellular events associated with ischemia/reperfusion injury. Ann Transplant 5 (2000) 29-35
26. Mallick I.H., Yang W., Winslet M.C., et al. Ischemia-reperfusion injury of the intestine and protective strategies against injury. Digest Dis Sci 49 (2004) 1359-1377
27. Massberg S., Gonzalez A.P., Leiderer R., et al. In vivo assessment of the influence of cold preservation time on microvascular reperfusion injury after experimental small bowel transplantation. Br J Surg 85 (1998) 127-133
28. Lee J.C., Latdon J.T., McDonnell P.C., et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372 (1994) 739-746
29. Farmer D.G., McDiarmid S.V., Kuniyoshi J., et al. Intragraft expression of messenger RNA for interleukin-6 and tumor necrosis-α is a predictor of rat small intestine transplant rejection. J Surg Res 57 (1994) 138-142
30. Frangogiannis N.G. Targeting the inflammatory response in healing myocardial infarcts. Curr Med Chem 13 (2006) 1877-1893
31. Farmer D.G., Shen X.D., Amersi F., et al. CD62 blockade with P-selectin glycoprotein ligand-immunoglobulin fusion protein reduces ischemia-reperfusion injury after rat intestinal transplantation. Transplantation 79 (2005) 44-51
32. Sisley A.C., Desai T., Harig J.M., et al. Neutrophil depletion attenuates human intestinal reperfusion injury. J Surg Res 57 (1994) 192-196
33. Hansen P.R. Role of neutrophils in myocardial ischemia and reperfusion. Circulation 91 (1995) 1872-1885